Brawn Biotech Limited (BOM:530207)
India · Delayed Price · Currency is INR 21.05
-1.05 (-4.75%)
At close: Nov 6, 2026
Brawn Biotech Market Cap
Brawn Biotech has a market cap or net worth of 63.16 million as of November 6, 2026. It is the 50,005th most valuable company in the world and the 5,417th biggest in India. Its market cap has increased by 4.67% in one year.
Market Cap
63.16M
Enterprise Value
61.28M
Revenue
180.90M
Global Rank
Country Rank
#5,417 India
PE Ratio
7.96
ChartMarket Cap Chart
Since August 11, 2005, Brawn Biotech's market cap has increased from 23.22M to 63.16M, an increase of 171.96%. That is a compound annual growth rate of 4.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 63.16M | -2.14% |
| Dec 31, 2025 | 64.54M | 0.94% |
| Dec 31, 2024 | 63.94M | -2.69% |
| Dec 26, 2023 | 65.71M | 11.17% |
| Dec 30, 2022 | 59.11M | -13.79% |
| Dec 31, 2021 | 68.56M | -6.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Norris Medicines | 146.71M |
| Desh Rakshak Aushdhalaya | 139.61M |
| Unjha Formulations | 124.92M |
| Beryl Drugs | 117.87M |
| Emmessar Biotech & Nutrition | 113.61M |
| Ortin Global | 101.81M |
| Ganga Pharmaceuticals | 73.89M |
| Vivanza Biosciences | 54.40M |